Navigation Links
Cadence Pharmaceuticals Estimates Fourth Quarter 2012 Net Product Revenue and Provides Full Year 2013 Revenue Guidance
Date:1/23/2013

The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the Investors page of www.cadencepharm.com under "Events & Presentations" by selecting "Corporate Overview."

Forward-Looking Statements
Statements included in this press release and Cadence's conference call that are not a description of historical facts are forward-looking statements. Words such as "plans," "believes," "expects," "anticipates," and "will," and similar expressions, are intended to identify forward-looking statements, and are based on Cadence's current beliefs and expectations. Such statements include, without limitation, statements regarding: Cadence's fourth quarter 2012 net product revenue estimate and the company's guidance regarding net product revenue from sales of OFIRMEV for the twelve months ending December 31, 2013. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Cadence's actual future results may differ materially from Cadence's current expectations due to the risks and uncertainties inherent in its business. These risks include, but are not limited to: Cadence's dependence on the successful commercialization of OFIRMEV, which is the company's only product; Cadence's ability to achieve broad market acceptance and generate revenues from sales of OFIRMEV; Cadence's dependence on its contract manufacturers and its ability to ensure an adequate and continued supply of OFIRMEV to meet market demand; Cadence's ability to successfully enforce its marketing exclusivities and intellectual property rights, and to defend the patents covering OFIRMEV, including in current patent litigation with the parties that are seeking to market generic versions of OFIRMEV; the potential that Cadence may be required to continue patent litigation for substantial lengths of time or file additional lawsuits to defend its patent rights from challenges by
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
2. Cadence Pharmaceuticals to Host Analyst and Investor Day
3. Cadence to Open Finished Medical Device Facility
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Piper Jaffray 24th Annual Healthcare Conference In New York City On November 28, 2012
5. Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
6. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2012 Financial Results On November 5, 2012
7. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
8. Cadence Pharmaceuticals To Present At The Wedbush PACGROW Life Sciences Management Access Conference In New York City On August 14, 2012
9. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2012 Financial Results On August 2, 2012
10. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
11. Vanda Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on February 12, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 ... Summary GlobalData,s new ... provides key market data on the Brazil Gynecological ... of US dollars, volume (in units) and average ... Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and ...
(Date:9/17/2014)... Sept. 17, 2014  Levi & Korsinsky, LLP is ... possible claims of breaches of fiduciary duty by the ... get more information, click here: http://zlk.9nl.com/alexza-pharmaceuticals-alxa . There ... If you own common stock in Alexza Pharmaceuticals Inc. ... Eduard Korsinsky, Esq. either via email at ...
(Date:9/17/2014)... PITTSBURGH , Sept. 17, 2014 /PRNewswire-iReach/ ... a white paper discussing improvements in the ... anatomic structures for both normal and diseased ... real-time information, simplifies surgical procedures, lowers surgical ... robot-assisted surgical procedures. The ...
Breaking Medicine Technology:Brazil Gynecological Devices Market Outlook to 2020 2Brazil Gynecological Devices Market Outlook to 2020 3Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2
... ... Schizophrenia, WASHINGTON, MAY 6 Data ... candidate,iloperidone, included its 4-week, short-term Phase III trial, as well as ... of iloperidone. Iloperidone is a 5HT2/D2 antagonist ("atypical"),antipsychotic currently under review ...
... - Data Presented in Poster Session at American College ... Gynecologists, 56th Annual ... PEAK Surgical, Inc., a medical,device company that is ... released results from a preclinical study,demonstrating that its PEAK ...
Cached Medicine Technology:Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 2Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 3Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 4Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 5Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 6Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 7PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery 2PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery 3PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery 4
(Date:9/18/2014)... 2014 N-Zyme Scientifics LLC achieved a ... first product a mere 8 months after company startup. ... performance glycan release enzyme used in the “Biologics” industry ... basis for tissue pathology on Mass Spec devices. PRIME™ ... the North American market (PNGase F PRIMETM). N-Zyme ...
(Date:9/18/2014)... 2014 9Lover.com, an internationally well-known designer ... launched a big promotion for its maternity wedding outfits. ... buy discounted maternity wedding dresses on its ... to all global consumers. The company’s development manager believes ... of ladies delighted. The current special offer will last ...
(Date:9/17/2014)... Fecbek, a leading dress manufacturer and retailer, has delightedly announced ... a lot of beautiful A-line dresses, maxi dresses, mini dresses ... skirt is a tube- or cone-shaped garment that hangs from ... In the western world, skirts are considered women's clothing. At ... is made out of a single piece of material (such ...
(Date:9/17/2014)... Recently, UWDress.com, an innovative company that provides many ... has released its 2014 empire waist evening dress ... a big sale for these new and beautiful products. ... rates, from 15 to 65 percent off. , ... comfortable to wear materials. Its elegant items include gold ...
(Date:9/17/2014)... (PRWEB) September 18, 2014 IntimateRider, an ... disabled adults , has announced that it has entered ... Medical & Mobility LLC. A primary reason for the ... Mobility's distribution reach is global. About its sales potential, ... strive to provide you with the latest products on ...
Breaking Medicine News(10 mins):Health News:N-Zyme Scientifics Announces Successful Product Launch 2Health News:Discounted Maternity Wedding Dresses For 2014 Introduced By 9Lover.com 2Health News:Fecbek.com Has Recently Announced Its New Series of Delicate Special Occasion Gowns Online 2Health News:2014 Empire Waist Evening Dress Collection Now Unveiled At UWDress.com 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 3
... one in 70 schoolchildren, available data says. The question is ... joint team of scientists from the King's College London ... up a seven-year study and hope to rope in 480 ... studied are between four and 11 months and already have ...
... news for the Bush administration in the US. A ... and Afghanistan is posing a serious challenge on two fronts. ... of mental health problems. Second at the current level of ... able to provide those affected necessary statement. ,In ...
... a campaign to encourage Hispanics to eat healthier food, ... Hispanics increased from 11.6% in 1991 to 23.7% in ... and two times more likely to have diabetes than ... ,LNC's campaign features a "Latin American Diet ...
... in the reduction of Alzheimer’s symptoms in mice. This promises ... a deadly brain disorder, scientists hope. ,Dr. Lennart ... this strategy also works in humans, it could enable a ... whose work is published in the journal Science, studied mice ...
... spectacle when she had epileptic seizures, almost 30 a day. What ... had a scowl and a guttural sinister laughter would emanate from ... to be named as "The Joker face," by her physician, Dr. ... ,This girl, all of 3 years suffered a very uncommon ...
... and practice is needed to achieve dignified care for older ... ,The welfare of older people who live in care homes ... McMurdo and Miles Witham at the University of Dundee. ... to dignity, but people of all ages have a fundamental ...
Cached Medicine News:Health News:UK Scientists to Undertake Seven Year Study of Peanut Allergy 2Health News:One Third of US Troops Suffer from Mental Health Problems 2Health News:One Third of US Troops Suffer from Mental Health Problems 3Health News:Major Change Needed to Achieve Dignified Care for Older People 2
Heavy duty, all purpose illuminator available in black only. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentrated l...
Convenient clip-activated switch with removable cobalt blue filter attachment....
Convenient clip-activated switch with imprinted 2 mm - 9 mm pupil gauge and medical caduceus....
... most affordable, compact and lightweight video magnifier. ... 18 pounds, the Companion is the perfect ... Companions easy-to-use controls allow you to read ... magazines, newspapers and even curved surfaces on ...
Medicine Products: